Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artelac is a brand of eye drops primarily known for its formulation containing hypromellose, which acts as a lubricant to treat symptoms of dry eye. It is a soothing solution used as an artificial tear when the eyes are lacking in natural tears. The hypromellose in these drops increases the thickness of the solution, providing a moisturizing effect and helping the solution stay in contact with the eye for a longer period of time. Different formulations within the Artelac brand contain various ingredients such as sodium hyaluronate, carbomer, glycerol, and lipid components to provide hydration and relief from dry eye symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Artelac.